On January 3, 2023 Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and oncology, reported that Antengene will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11th, 2023 at 9:30 a.m. PST in San Francisco, California (Press release, Antengene, JAN 3, 2023, View Source [SID1234625765]). The presentation will be made by Dr. Jay Mei, Antengene’s Founder, Chairman and CEO.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Details of the event are as follow:
41st Annual J.P. Morgan Healthcare Conference
JPM Presentation Date: Wednesday, January 11th, 2023
JPM Presentation Time: 9:30 am PST, followed by a short question and answer session
Presenter: Dr. Jay Mei, Antengene’s Founder, Chairman and CEO
Participating in Q&A: Members of Antengene Management
Webcast Link: View Source;kiosk=true
1X1/Small Group Meetings: Monday, January 9th, 2023 to Thursday, January 12th, 2023 for Investor and Business Development Meetings
*To schedule a meeting, please contact Antengene’s Investor Relations Team at [email protected]
An archived version of the presentation also will be available on the Company website following the live presentation.